Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Острый риносинусит: диагностика и лечение
Острый риносинусит: диагностика и лечение
Дербенева М.Л., Гусева А.Л. Острый риносинусит: диагностика и лечение. Consilium Medicum. 2018; 20 (3): 58–60. DOI: 10.26442/2075-1753_20.3.58-60
________________________________________________
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Аннотация
В статье представлены этиология, клиническая картина и диагностические критерии острого риносинусита. Рассматриваются дифференциальная диагностика острого риносинусита вирусной и бактериальной этиологии, а также особенности назначения антибактериальной и сопутствующей вспомогательной терапии при этом заболевании.
Ключевые слова: синусит, риносинусит, антибиотики.
Key words: sinusitis, rhinosinusitis, antibiotics.
Ключевые слова: синусит, риносинусит, антибиотики.
________________________________________________
Key words: sinusitis, rhinosinusitis, antibiotics.
Полный текст
Список литературы
1. Rosenfeld RM. Clinical Practice. Acute Sinusitis in Adults. N Engl J Med 2016 8; 375 (10): 962–70. DOI: 10.1056/NEJMcp1601749
2. Острый риносинусит: клинические рекомендации. Под ред. А.С.Лопатина. Российское общество ринологов. М., 2017. / Ostryi rinosinusit: klinicheskie rekomendatsii. Pod red. A.S.Lopatina. Rossiiskoe obshchestvo rinologov. M., 2017. [in Russian]3. Shappert SM, Rechtsteiner EA. Ambulatory medical care utilization estimates for 2007. Vital Health Stat 2011; 13 (169): 1Y38.
4. Крюков А.И., Студеный М.Е., Артемьев М.Е. и др. Лечение пациентов с риносинуситами: возможности консервативного и оперативного воздействия. Мед. совет. 2012; 11: 52–6. / Kriukov A.I., Studenyi M.E., Artem'ev M.E. i dr. Lechenie patsientov s rinosinusitami: vozmozhnosti konservativnogo i operativnogo vozdeistviia. Med. sovet. 2012; 11: 52–6. [in Russian]
5. Gwaltney JM Jr. Acute communityacquired sinusitis. Clin Infect Dis 1996; 23: 1209–23.
6. Puhakka T, Mäkelä MJ, Alanen A et al. Sinusitis in the common cold. J Allergy Clin Immunol 1998; 102: 403–8.
7. Hadley JA, Pfaller MA. Oral beta-lactams in the treatment of acute bacterial rhinosinusitis. Diagn Microbiol Infect Dis 2007; 57 (Suppl. 3): 47S–54S.
8. Sokol W. Epidemiology of sinusitis in the primary care setting: results from the 1999-2000 Respiratory Surveillance Program. Am J Med 2001; 111 (Suppl. 9A): 19S–24S.
9. Burgstaller JM, Steurer J, Holzmann D et al. Antibiotic efficacy in patients with a moderate probability of acute rhinosinusitis: a systematic review. Eur Arch Otorhinolaryngol 2016; 273: 1067–77.
10. Jones BE, Sauer B, Jones MM et al. Variation in Outpatient Antibiotic Prescribing for Acute Respiratory Infections in the Veteran Population: A Cross-sectional Study. Ann Intern Med. 2015; 163 (2): 73–80. DOI: 10.7326/M14-1933
11. Gulliford MC, Dregan A, Moore MV et al. Continued high rates of antibiotic prescribing to adults with respiratory tract infection: survey of 568 UK general practices. BMJ Open 2014; 4 (10): e006245. DOI: 10.1136/bmjopen-2014-006245
12. Desrosiers M, Evans GA, Keith PK et al. Canadian clinical practice guidelines for acute and chronic rhinosinusitis. Allergy Asthma Clin Immunol 2011; 7 (1): 2. DOI: 10.1186/1710-1492-7-2
13. Gwaltney JM. Clinical significance and pathogenesis of viral respiratory infections. Am J Med 2002; 112 (Suppl. 6A): 13S–18S.
14. Hauer AJ, Luiten EL, van Erp NF et al. No evidence for distinguishing bacterial from viral acute rhinosinusitis using fever and facial/dental pain: a systematic review of the evidence base. Otolaryngol Head Neck Surg. 2014; 150 (1): 28–33. DOI: 10.1177/0194599813510891
15. Van den Broek MF, Gudden C, Kluijfhout WP et al. No evidence for distinguishing bacterial from viral acute rhinosinusitis using symptom duration and purulent rhinorrhea: a systematic review of the evidence base. Otolaryngol Head Neck Surg 2014; 150 (4): 533–7. DOI: 10.1177/0194599814522595
16. Lacroix JS, Ricchetti A, Lew D et al. Symptoms and clinical and radiological signs predicting the presence of pathogenic bacteria in acute rhinosinusitis. Acta Otolaryngol 2002; 122 (2): 192–6.
17. Hoxworth JM, Glastonbury CM. Orbital and intracranial complications of acute sinusitis. Neuroimaging Clin N Am 2010; 20: 511–26.
18. Рязанцев С.В., Карнеева О.В., Гаращенко Т.И. и др. Острый синусит. Клинические рекомендации Национальной медицинской ассоциации оториноларингологов. 2016. / Riazantsev S.V., Karneeva O.V., Garashchenko T.I. i dr. Ostryi sinusit. Klinicheskie rekomendatsii Natsional'noi meditsinskoi assotsiatsii otorinolaringologov. 2016. [in Russian]
19. Berger G, Berger RL. The contribution of flexible endoscopy for diagnosis of acute bacterial rhinosinusitis. Eur Arch Otorhinolaryngol 2011; 268: 235Y240.
20. Lemiengre MB, van Driel ML, Merenstein D et al. Antibiotics for clinically diagnosed acute rhinosinusitis in adults. Cochrane Database Syst Rev 2012; 10: CD006089. DOI: 10.1002/14651858.CD006089.pub4
21. Fokkens WJ, Lund VJ, Mullol J et al. EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. Rhinology 2012; 50 (1): 1–12. DOI: 10.4193/Rhino50E2.
22. FDA Drug Safety Communication: FDA advises restricting fluoroquinolone antibiotic use for certain uncomplicated infections; warns about disabling side effects that can occur together. Silver Spring, MD: Food and Drug Administration, May 12, 2016 (http://www .fda .gov/Drugs/ DrugSafety/ ucm500143.htm)
23. Meltzer EO, Bachert C, Staudinger H. Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. J Allergy Clin Immunol 2005; 116 (6): 1289–95.
24. Zalmanovici Trestioreanu A, Yaphe J. Intranasal steroids for acute sinusitis. Cochrane Database Syst Rev 2013; 12: CD005149. DOI: 10.1002/14651858.CD005149.pub4
25. Taverner D, Latte J. Nasal decongestants for the common cold. Cochrane Database Syst Rev 2007; 1: CD001953.
26. Jund R, Mondigler M, Steindl H et al; ARhiSi II study group. Clinical efficacy of a dry extract of five herbal drugs in acute viral rhinosinusitis. Rhinology 2012; 50 (4): 417–26. DOI: 10.4193/Rhino12.015.
27. King D, Mitchell B, Williams CP, Spurling GK. Saline nasal irrigation for acute upper respiratory tract infections. Cochrane Database Syst Rev 2015; 4: CD006821. DOI: 10.1002/14651858.CD006821.pub3
________________________________________________
1. Rosenfeld RM. Clinical Practice. Acute Sinusitis in Adults. N Engl J Med 2016 8; 375 (10): 962–70. DOI: 10.1056/NEJMcp1601749
2. Ostryi rinosinusit: klinicheskie rekomendatsii. Pod red. A.S.Lopatina. Rossiiskoe obshchestvo rinologov. M., 2017. [in Russian]
3. Shappert SM, Rechtsteiner EA. Ambulatory medical care utilization estimates for 2007. Vital Health Stat 2011; 13 (169): 1Y38.
4. Kriukov A.I., Studenyi M.E., Artem'ev M.E. i dr. Lechenie patsientov s rinosinusitami: vozmozhnosti konservativnogo i operativnogo vozdeistviia. Med. sovet. 2012; 11: 52–6. [in Russian]
5. Gwaltney JM Jr. Acute communityacquired sinusitis. Clin Infect Dis 1996; 23: 1209–23.
6. Puhakka T, Mäkelä MJ, Alanen A et al. Sinusitis in the common cold. J Allergy Clin Immunol 1998; 102: 403–8.
7. Hadley JA, Pfaller MA. Oral beta-lactams in the treatment of acute bacterial rhinosinusitis. Diagn Microbiol Infect Dis 2007; 57 (Suppl. 3): 47S–54S.
8. Sokol W. Epidemiology of sinusitis in the primary care setting: results from the 1999-2000 Respiratory Surveillance Program. Am J Med 2001; 111 (Suppl. 9A): 19S–24S.
9. Burgstaller JM, Steurer J, Holzmann D et al. Antibiotic efficacy in patients with a moderate probability of acute rhinosinusitis: a systematic review. Eur Arch Otorhinolaryngol 2016; 273: 1067–77.
10. Jones BE, Sauer B, Jones MM et al. Variation in Outpatient Antibiotic Prescribing for Acute Respiratory Infections in the Veteran Population: A Cross-sectional Study. Ann Intern Med. 2015; 163 (2): 73–80. DOI: 10.7326/M14-1933
11. Gulliford MC, Dregan A, Moore MV et al. Continued high rates of antibiotic prescribing to adults with respiratory tract infection: survey of 568 UK general practices. BMJ Open 2014; 4 (10): e006245. DOI: 10.1136/bmjopen-2014-006245
12. Desrosiers M, Evans GA, Keith PK et al. Canadian clinical practice guidelines for acute and chronic rhinosinusitis. Allergy Asthma Clin Immunol 2011; 7 (1): 2. DOI: 10.1186/1710-1492-7-2
13. Gwaltney JM. Clinical significance and pathogenesis of viral respiratory infections. Am J Med 2002; 112 (Suppl. 6A): 13S–18S.
14. Hauer AJ, Luiten EL, van Erp NF et al. No evidence for distinguishing bacterial from viral acute rhinosinusitis using fever and facial/dental pain: a systematic review of the evidence base. Otolaryngol Head Neck Surg. 2014; 150 (1): 28–33. DOI: 10.1177/0194599813510891
15. Van den Broek MF, Gudden C, Kluijfhout WP et al. No evidence for distinguishing bacterial from viral acute rhinosinusitis using symptom duration and purulent rhinorrhea: a systematic review of the evidence base. Otolaryngol Head Neck Surg 2014; 150 (4): 533–7. DOI: 10.1177/0194599814522595
16. Lacroix JS, Ricchetti A, Lew D et al. Symptoms and clinical and radiological signs predicting the presence of pathogenic bacteria in acute rhinosinusitis. Acta Otolaryngol 2002; 122 (2): 192–6.
17. Hoxworth JM, Glastonbury CM. Orbital and intracranial complications of acute sinusitis. Neuroimaging Clin N Am 2010; 20: 511–26.
18. Riazantsev S.V., Karneeva O.V., Garashchenko T.I. i dr. Ostryi sinusit. Klinicheskie rekomendatsii Natsional'noi meditsinskoi assotsiatsii otorinolaringologov. 2016. [in Russian]
19. Berger G, Berger RL. The contribution of flexible endoscopy for diagnosis of acute bacterial rhinosinusitis. Eur Arch Otorhinolaryngol 2011; 268: 235Y240.
20. Lemiengre MB, van Driel ML, Merenstein D et al. Antibiotics for clinically diagnosed acute rhinosinusitis in adults. Cochrane Database Syst Rev 2012; 10: CD006089. DOI: 10.1002/14651858.CD006089.pub4
21. Fokkens WJ, Lund VJ, Mullol J et al. EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. Rhinology 2012; 50 (1): 1–12. DOI: 10.4193/Rhino50E2.
22. FDA Drug Safety Communication: FDA advises restricting fluoroquinolone antibiotic use for certain uncomplicated infections; warns about disabling side effects that can occur together. Silver Spring, MD: Food and Drug Administration, May 12, 2016 (http://www .fda .gov/Drugs/ DrugSafety/ ucm500143.htm)
23. Meltzer EO, Bachert C, Staudinger H. Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. J Allergy Clin Immunol 2005; 116 (6): 1289–95.
24. Zalmanovici Trestioreanu A, Yaphe J. Intranasal steroids for acute sinusitis. Cochrane Database Syst Rev 2013; 12: CD005149. DOI: 10.1002/14651858.CD005149.pub4
25. Taverner D, Latte J. Nasal decongestants for the common cold. Cochrane Database Syst Rev 2007; 1: CD001953.
26. Jund R, Mondigler M, Steindl H et al; ARhiSi II study group. Clinical efficacy of a dry extract of five herbal drugs in acute viral rhinosinusitis. Rhinology 2012; 50 (4): 417–26. DOI: 10.4193/Rhino12.015.
27. King D, Mitchell B, Williams CP, Spurling GK. Saline nasal irrigation for acute upper respiratory tract infections. Cochrane Database Syst Rev 2015; 4: CD006821. DOI: 10.1002/14651858.CD006821.pub3
2. Ostryi rinosinusit: klinicheskie rekomendatsii. Pod red. A.S.Lopatina. Rossiiskoe obshchestvo rinologov. M., 2017. [in Russian]
3. Shappert SM, Rechtsteiner EA. Ambulatory medical care utilization estimates for 2007. Vital Health Stat 2011; 13 (169): 1Y38.
4. Kriukov A.I., Studenyi M.E., Artem'ev M.E. i dr. Lechenie patsientov s rinosinusitami: vozmozhnosti konservativnogo i operativnogo vozdeistviia. Med. sovet. 2012; 11: 52–6. [in Russian]
5. Gwaltney JM Jr. Acute communityacquired sinusitis. Clin Infect Dis 1996; 23: 1209–23.
6. Puhakka T, Mäkelä MJ, Alanen A et al. Sinusitis in the common cold. J Allergy Clin Immunol 1998; 102: 403–8.
7. Hadley JA, Pfaller MA. Oral beta-lactams in the treatment of acute bacterial rhinosinusitis. Diagn Microbiol Infect Dis 2007; 57 (Suppl. 3): 47S–54S.
8. Sokol W. Epidemiology of sinusitis in the primary care setting: results from the 1999-2000 Respiratory Surveillance Program. Am J Med 2001; 111 (Suppl. 9A): 19S–24S.
9. Burgstaller JM, Steurer J, Holzmann D et al. Antibiotic efficacy in patients with a moderate probability of acute rhinosinusitis: a systematic review. Eur Arch Otorhinolaryngol 2016; 273: 1067–77.
10. Jones BE, Sauer B, Jones MM et al. Variation in Outpatient Antibiotic Prescribing for Acute Respiratory Infections in the Veteran Population: A Cross-sectional Study. Ann Intern Med. 2015; 163 (2): 73–80. DOI: 10.7326/M14-1933
11. Gulliford MC, Dregan A, Moore MV et al. Continued high rates of antibiotic prescribing to adults with respiratory tract infection: survey of 568 UK general practices. BMJ Open 2014; 4 (10): e006245. DOI: 10.1136/bmjopen-2014-006245
12. Desrosiers M, Evans GA, Keith PK et al. Canadian clinical practice guidelines for acute and chronic rhinosinusitis. Allergy Asthma Clin Immunol 2011; 7 (1): 2. DOI: 10.1186/1710-1492-7-2
13. Gwaltney JM. Clinical significance and pathogenesis of viral respiratory infections. Am J Med 2002; 112 (Suppl. 6A): 13S–18S.
14. Hauer AJ, Luiten EL, van Erp NF et al. No evidence for distinguishing bacterial from viral acute rhinosinusitis using fever and facial/dental pain: a systematic review of the evidence base. Otolaryngol Head Neck Surg. 2014; 150 (1): 28–33. DOI: 10.1177/0194599813510891
15. Van den Broek MF, Gudden C, Kluijfhout WP et al. No evidence for distinguishing bacterial from viral acute rhinosinusitis using symptom duration and purulent rhinorrhea: a systematic review of the evidence base. Otolaryngol Head Neck Surg 2014; 150 (4): 533–7. DOI: 10.1177/0194599814522595
16. Lacroix JS, Ricchetti A, Lew D et al. Symptoms and clinical and radiological signs predicting the presence of pathogenic bacteria in acute rhinosinusitis. Acta Otolaryngol 2002; 122 (2): 192–6.
17. Hoxworth JM, Glastonbury CM. Orbital and intracranial complications of acute sinusitis. Neuroimaging Clin N Am 2010; 20: 511–26.
18. Riazantsev S.V., Karneeva O.V., Garashchenko T.I. i dr. Ostryi sinusit. Klinicheskie rekomendatsii Natsional'noi meditsinskoi assotsiatsii otorinolaringologov. 2016. [in Russian]
19. Berger G, Berger RL. The contribution of flexible endoscopy for diagnosis of acute bacterial rhinosinusitis. Eur Arch Otorhinolaryngol 2011; 268: 235Y240.
20. Lemiengre MB, van Driel ML, Merenstein D et al. Antibiotics for clinically diagnosed acute rhinosinusitis in adults. Cochrane Database Syst Rev 2012; 10: CD006089. DOI: 10.1002/14651858.CD006089.pub4
21. Fokkens WJ, Lund VJ, Mullol J et al. EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. Rhinology 2012; 50 (1): 1–12. DOI: 10.4193/Rhino50E2.
22. FDA Drug Safety Communication: FDA advises restricting fluoroquinolone antibiotic use for certain uncomplicated infections; warns about disabling side effects that can occur together. Silver Spring, MD: Food and Drug Administration, May 12, 2016 (http://www .fda .gov/Drugs/ DrugSafety/ ucm500143.htm)
23. Meltzer EO, Bachert C, Staudinger H. Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. J Allergy Clin Immunol 2005; 116 (6): 1289–95.
24. Zalmanovici Trestioreanu A, Yaphe J. Intranasal steroids for acute sinusitis. Cochrane Database Syst Rev 2013; 12: CD005149. DOI: 10.1002/14651858.CD005149.pub4
25. Taverner D, Latte J. Nasal decongestants for the common cold. Cochrane Database Syst Rev 2007; 1: CD001953.
26. Jund R, Mondigler M, Steindl H et al; ARhiSi II study group. Clinical efficacy of a dry extract of five herbal drugs in acute viral rhinosinusitis. Rhinology 2012; 50 (4): 417–26. DOI: 10.4193/Rhino12.015.
27. King D, Mitchell B, Williams CP, Spurling GK. Saline nasal irrigation for acute upper respiratory tract infections. Cochrane Database Syst Rev 2015; 4: CD006821. DOI: 10.1002/14651858.CD006821.pub3
Авторы
М.Л.Дербенева*1, А.Л.Гусева2
1 ГБУЗ «Городская клиническая больница №1 им. Н.И.Пирогова» Департамента здравоохранения г. Москвы. 117049, Россия, Москва, Ленинский пр-т., д. 10, корп. 5;
2 ФГБОУ ВО «Российский национальный исследовательский медицинский университет им. Н.И.Пирогова» Минздрава России. 117997, Россия, Москва, ул. Островитянова, д. 1
1 N.I.Pirogov City Сlinical Hospital №1 of the Department of Health of Moscow. 119049, Russian Federation, Moscow, Leninskii pr-t, d. 10, korp. 5;
2 N.I.Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation. 117997, Russian Federation, Moscow, ul. Ostrovitianova, d. 1
*mlderbeneva@mail.ru
2 ФГБОУ ВО «Российский национальный исследовательский медицинский университет им. Н.И.Пирогова» Минздрава России. 117997, Россия, Москва, ул. Островитянова, д. 1
________________________________________________
1 N.I.Pirogov City Сlinical Hospital №1 of the Department of Health of Moscow. 119049, Russian Federation, Moscow, Leninskii pr-t, d. 10, korp. 5;
2 N.I.Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation. 117997, Russian Federation, Moscow, ul. Ostrovitianova, d. 1
*mlderbeneva@mail.ru
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.